Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-10

Clinical Trial Update: Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial update notes continued administration of G-202 for one patient with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • G-202

Snippet

Sponsor: Devalingam Mahalingam | Conditions: Hepatocellular Carcinoma | Status: NO_LONGER_AVAILABLE